Published in Br J Pharmacol on September 01, 1973
Interactions of (+)-amphetamine and chlorpromazine on neurones in the lower brain stem of the rat. Br J Pharmacol (1979) 0.75
The marking of electrode tip positions in nervous tissue. J Physiol (1971) 2.05
A neuronal basis for the alerting action of (+)-amphetamine. Br J Pharmacol (1972) 1.55
The effect of chlorpromazine and methopromazine on the electrical activity of the brain in the cat. Electroencephalogr Clin Neurophysiol (1957) 1.49
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Br J Pharmacol (1970) 2.49
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 2.47
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Pharmacological properties of cholinoceptive neurones in the medulla and pons of the cat. J Physiol (1966) 1.88
Actions of prostaglandins E1, E2, and F2-alpha on brain stem neurones. Br J Pharmacol Chemother (1966) 1.84
Synaptic transmission in the central nervous system and its relevance for drug action. Int Rev Neurobiol (1968) 1.77
Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun (1995) 1.76
Iontophoretic release of acetylcholine, noradrenaline, 5-hydroxytryptamine and D-lysergic acid diethylamide from micropipettes. Br J Pharmacol (1970) 1.72
Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun (1995) 1.72
Morphine and neurotransmitter substances: Microiontophoretic study in the rat brain stem. Br J Pharmacol (1974) 1.65
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
A neuronal basis for the alerting action of (+)-amphetamine. Br J Pharmacol (1972) 1.55
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
Modification of the responses of brain stem neurones to transmitter substances by anaesthetic agents. Br J Pharmacol (1973) 1.34
Actions and interactions of narcotic agonists and antagonists on brain stem neurones. Brain Res (1974) 1.26
The effects of different anaesthetics on responses of brain stem neurones to iontophoretically applied transmitter substances. Br J Pharmacol (1972) 1.24
Actions of noradrenaline, other sympathomimetic amines and antagonists on neurones in the brain stem of the cat. Br J Pharmacol (1971) 1.22
Stereoscpecific actions of morphine on single neurones in the brain stem of the rat. Neuropharmacology (1977) 1.15
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett (1982) 1.14
Pharmacological properties of neurons of the paramedian reticular nucleus. Experientia (1966) 1.07
A stereospecific action of morphine on brain stem neuronal activity: a microiontophoretic study. Br J Pharmacol (1975) 1.06
Effects of microiontophoretically applied methionine-enkephalin on single neurones in rat brain. Nature (1976) 1.06
Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery. Br J Pharmacol (1986) 1.05
Actions and interactions of microiontophoretically applied morphine with transmitter substances on brain stem neurones. Br J Pharmacol (1973) 1.05
Short-latency excitation of brain stem neurones in the rat by acetylcholine. Br J Pharmacol (1972) 1.02
Molecular evolutionary analysis of the thiamine-diphosphate-dependent enzyme, transketolase. J Mol Evol (1997) 1.01
Cerebellar structure and function in the murine mutant "jolting". J Neurol Sci (1986) 1.01
5HT2 receptor changes in major depression. Biol Psychiatry (1990) 1.00
Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem (1986) 1.00
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Localization with Pontamine Sky Blue of neurones in the brainstem responding to microiontophoretically applied compounds. Neuropharmacology (1974) 0.98
Aluminium and the pathogenesis of senile plaques in Alzheimer's disease, Down's syndrome and chronic renal dialysis. Ann Med (1989) 0.98
Differences in benzodiazepine receptor binding in Maudsley reactive and Maudsley non-reactive rats. Eur J Pharmacol (1978) 0.97
Excitatory action of prostaglandin E-1 on brain-stem neurones. Nature (1966) 0.96
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry (1987) 0.96
Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Br J Pharmacol (1985) 0.96
Antagonism by LSD to effects of 5-HT on single neurones. Brain Res (1969) 0.96
Correlation of the release of amines and antagonists with their effects. Neuropharmacology (1974) 0.94
Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett (1995) 0.94
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain (1991) 0.93
Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia (1995) 0.92
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat (1984) 0.92
Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet (1983) 0.91
Agonistic and antagonistic effects of alpha-methylnoradrenaline at central receptors. Brain Res (1968) 0.91
Effects of lysergic acid derivatives on 5-hydroxytryptamine excitation of brain stem neurones. Br J Pharmacol (1970) 0.91
Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine. Br J Pharmacol (1974) 0.90
Protective effect of apoE epsilon 2 in Alzheimer's disease. Lancet (1994) 0.89
Cholinergic receptors in cognitive disorders. Can J Neurol Sci (1986) 0.89
Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett (1994) 0.88
Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease. Ciba Found Symp (1986) 0.88
Facilitation of benzodiazepine binding by sodium chloride and GABA. Neuropharmacology (1978) 0.88
Effects of substitution of aspartate-440 and tryptophan-487 in the thiamin diphosphate binding region of pyruvate decarboxylase from Zymomonas mobilis. FEBS Lett (1992) 0.86
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat. Neurosci Lett (1984) 0.85
Properties and possible significance of substance P and insulin fibrils. Neurosci Lett (1981) 0.85
Failure of (+)-naloxone to antagonise responses to opioid peptides. Neuropharmacology (1978) 0.84
Brain iron homeostasis. J Inorg Biochem (1992) 0.84
Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J Neurol Sci (1989) 0.84
Transferrin receptors in the parkinsonian midbrain. Neuropathol Appl Neurobiol (1994) 0.84
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neurosci Lett (1984) 0.84
Facilitation of specific benzodiazepine binding in rat brain membrane fragments by a number of anions. Neuropharmacology (1980) 0.83
The role of endogenous catecholamines in the regulation of electrocortical activity in the encephale isole cat. Electroencephalogr Clin Neurophysiol (1976) 0.83
Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp (1992) 0.83
Correlation of prostaglandin release from the cerebral cortex of cats with the electrocorticogram, following stimulation of the reticular formation. Br J Pharmacol (1969) 0.82
Cholinoceptive properties of respiratory neurones in the rat medulla. Neuropharmacology (1983) 0.82
Abolition of the response of brain stem neurones to iontophoretically applied d-amphetamine by reserpine. Nature (1971) 0.81
Postmortem neurochemical studies in depression. Ann N Y Acad Sci (1986) 0.81
Evidence for the localization of haemopexin immunoreactivity in neurones in the human brain. Neurosci Lett (1993) 0.81
Electrophysiological studies with a new anti-depressant drug: comparison of the effects of viloxazine (ICI 58,834) with three tricyclic anti-depressants in the encéphale isolé. Neuropharmacology (1978) 0.81
Raising the ambient potassium ion concentration enhances carbachol stimulated phosphoinositide hydrolysis in rat brain hippocampal and cerebral cortical miniprisms. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.81
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. J Neurol Sci (1985) 0.81
A comparison of the actions of ergothioneine and chlorpromazine applied to single neurones by two different methods. Int J Neuropharmacol (1966) 0.81
Electrocortical changes in the encéphale isolé cat following chronic treatment with antidepressant drugs. Neuropharmacology (1979) 0.81
Content of brain aluminum is not elevated in Alzheimer disease. Alzheimer Dis Assoc Disord (1996) 0.80
Neocortical cholinergic enzyme and receptor activities in the human fetal brain. J Neurochem (1986) 0.80
Regional distribution of high-affinity [3H]somatostatin binding sites in the human brain. Brain Res (1986) 0.80
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neurosci Lett (1985) 0.79
Abnormal behavioural changes associated with vasopressin-induced barrel rotations. Brain Res (1985) 0.79
Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain. Neuropharmacology (1984) 0.79
Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J Neurol Sci (1990) 0.79
Working memory in aged rats. Behav Neurosci (1989) 0.79
Somatostatin content and receptors in the cerebral cortex of depressed and control subjects. J Neurol Neurosurg Psychiatry (1988) 0.78
Pharmacological and electrophysiological characteristics of neurones in the paramedian reticular nucleus. Arch Ital Biol (1975) 0.78